OMER
Omeros Corporation
NASDAQ: OMER · HEALTHCARE · BIOTECHNOLOGY
$14.60
+0.27% today
Updated 2026-04-30
Market cap
$1.06B
P/E ratio
—
P/S ratio
4.43x
EPS (TTM)
$-0.08
Dividend yield
—
52W range
$3 – $18
Volume
1.1M
Omeros Corporation (OMER) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-576.00%
ROA
-25.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $200000.00 | $-22.78M | 100.00% | -11,976.50% | -11,388.50% |
| 2007 | $1.92M | $-23.09M | 100.00% | -1,268.69% | -1,200.78% |
| 2008 | $1.17M | $-23.83M | 100.00% | -2,096.15% | -2,036.50% |
| 2009 | $1.44M | $-21.09M | 100.00% | -1,437.53% | -1,460.46% |
| 2010 | $2.10M | $-29.25M | 100.00% | -1,430.21% | -1,389.60% |
| 2011 | $4.52M | $-28.55M | 100.00% | -605.88% | -630.99% |
| 2012 | $6.02M | $-38.44M | 99.69% | -612.50% | -638.39% |
| 2013 | $1.60M | $-39.80M | -1,045.38% | -3,157.25% | -2,487.25% |
| 2014 | $539000.00 | $-73.67M | -4,858.81% | -12,988.50% | -13,668.46% |
| 2015 | $13.51M | $-75.10M | 92.29% | -527.34% | -555.90% |
| 2016 | $41.62M | $-66.75M | 96.61% | -130.42% | -160.38% |
| 2017 | $64.83M | $-53.48M | 98.34% | -67.71% | -82.50% |
| 2018 | $29.87M | $-126.76M | 98.29% | -375.73% | -424.39% |
| 2019 | $111.81M | $-84.49M | 97.63% | -56.69% | -75.57% |
| 2020 | $73.81M | $-138.06M | -2.19% | -212.59% | -187.04% |
| 2021 | $90.52M | $-111.41M | -1.53% | -191.80% | -123.08% |
| 2022 | $0.00 | $47.42M | — | — | — |
| 2023 | $0.00 | $-117.81M | — | — | — |
| 2024 | $0.00 | $-156.81M | — | — | — |
| 2025 | $0.00 | $-3.35M | — | — | — |